Literature DB >> 24687832

A major step forward for BRCA1/2-related cancer risk management.

Phuong L Mai1, Jennifer T Loud1, Mark H Greene2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24687832     DOI： 10.1200/JCO.2013.54.8925

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.

Authors:  Se Ik Kim; Myong Cheol Lim; Dong Ock Lee; Sun-Young Kong; Sang-Soo Seo; Sokbom Kang; Eun Sook Lee; Sang-Yoon Park
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-05       Impact factor: 4.553

2.  The fallopian tube: from back stage to center stage.

Authors:  Mark H Greene; Phuong L Mai
Journal:  Cancer Prev Res (Phila)       Date:  2015-03-23

3.  Quantitative assessment of background parenchymal enhancement in breast MRI predicts response to risk-reducing salpingo-oophorectomy: preliminary evaluation in a cohort of BRCA1/2 mutation carriers.

Authors:  Shandong Wu; Susan P Weinstein; Michael J DeLeo; Emily F Conant; Jinbo Chen; Susan M Domchek; Despina Kontos
Journal:  Breast Cancer Res       Date:  2015-05-19       Impact factor: 6.466

4.  Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer.

Authors:  Y C Lee; M Bressel; P Grant; P Russell; C Smith; S Picken; S Camm; B E Kiely; R L Milne; S A McLachlan; M Hickey; M L Friedlander; J L Hopper; K A Phillips
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

5.  Ovarian cancer: Pathogenesis and current recommendations for prophylactic surgery

Authors:  I Nyoman Gede Budiana; Michelle Angelina; Tjokorda Gede Astawa Pemayun
Journal:  J Turk Ger Gynecol Assoc       Date:  2018-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.